Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 10, 2017
Aradigm Announces Second Quarter 2017 Financial Results
HAYWARD, Calif. -- (BUSINESS WIRE) -- Aradigm Corporation (ARDM) (the “Company”) today announced financial results for the second quarter and six months ended June 30, 2017. ...
August 10, 2017
Zealand Pharma A/S publishes a prospectus regarding listing of 4,375,000 new shares on Nasdaq Copenhagen as part of its issue of American Depositary Shares listed on the Nasdaq in the US
Copenhagen, August 10, 2017 - With reference to company announcements (i) no. 29/2017 dated August 1, 2017 regarding launch of an initial public offering of American ...
August 9, 2017
Vermillion Reports Second Quarter 2017 Results
AUSTIN, Texas, Aug. 9, 2017 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for the second ...
August 9, 2017
BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update
RALEIGH, N.C., Aug. 9, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and six months ended June 30, ...
August 9, 2017
Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
AUSTIN, Texas, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino ...
August 9, 2017
SciClone Reports Second Quarter 2017 Financial Results
FOSTER CITY, Calif., Aug. 9, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) today reported financial results for the quarter ended June 30, 2017. Revenues: In the ...
August 9, 2017
Rockwell Medical Reports Second Quarter Results
WIXOM, Mich., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...
August 9, 2017
Heron Therapeutics Announces Initiation of Phase 3 Program for HTX-011 in Postoperative Pain Following Successful End-of-Phase 2 Meeting with FDA
SAN DIEGO -- (BUSINESS WIRE) -- Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address ...
August 9, 2017
Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress
SAN DIEGO, Calif. -- (BUSINESS WIRE) -- Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to ...
August 9, 2017
AC IMMUNE REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS
Lausanne, Switzerland, August 9, 2017 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
August 9, 2017
Aimmune Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference on Wednesday, August 16th
BRISBANE, Calif. -- (BUSINESS WIRE) -- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that CFO Eric Bjerkholt will ...
August 9, 2017
Lipocine Resubmits NDA for Its Oral Testosterone Product Candidate, LPCN 1021, for Treatment of Hypogonadism
SALT LAKE CITY, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced the resubmission of a New Drug Application ...
August 9, 2017
CYTOVIA Inc, IMMUNE Pharma’s Oncology Subsidiary, Announces Publication of Results Showing Anti-Metastatic Properties of Its Lead Drug Ceplene® and Filing of a New Worldwide Patent
NEW YORK -- (BUSINESS WIRE) -- Cytovia, the oncology subsidiary of Immune Pharmaceuticals Inc. (IMNP) ("Immune"), a clinical stage biopharmaceutical company, today announced the publication of ...
August 9, 2017
Zealand Pharma (Nasdaq: ZEAL) to Ring The Nasdaq Stock Market Opening Bell
Zealand Pharma (ZEAL.CO), a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines, will visit the Nasdaq MarketSite in Times Square. ...
August 8, 2017
Ignyta Announces Second Quarter 2017 Company Highlights and Financial Results
SAN DIEGO -- (BUSINESS WIRE) -- Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, today announced company highlights and financial results for the ...
August 8, 2017
Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings
NEW YORK, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported results ...
August 8, 2017
iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million Credit Facility With Silicon Valley Bank
NASHUA, N.H., Aug. 08, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the ...
August 8, 2017
Zogenix Provides Corporate Update and Reports Second Quarter 2017 Financial Results
EMERYVILLE, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system ...
August 8, 2017
Foamix Reports Second Quarter 2017 Financial Results and Provides Business Update
REHOVOT, Israel, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing ...
August 8, 2017
Aimmune Therapeutics Announces Second Quarter 2017 Financial Results
BRISBANE, California -- (BUSINESS WIRE) -- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced financial results for the quarter ...
Page 99 of 117